[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-ADPT":3,"homepage-market-summary":30,"stock-news-ADPT":172},{"ticker":4,"date":5,"profile":6,"quote":14},"ADPT","2026-10-01",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9},"Adaptive Biotechnologies Corporation Common Stock","Nasdaq",null,"BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)","Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.","624","Seattle, WA",{"close":15,"open":16,"high":17,"low":18,"prev_close":19,"change":20,"percent_change":21,"volume":22,"transactions":23,"vwap":24,"high_52w":25,"low_52w":26,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},27.37,28.885,29,27.145,28.9,-1.53,-5.29,5844434.004776,33736,28.2316,71.25,2.28,1368072.8705351627,36.4,1826,{"status":31,"indices":32,"watchlist":74,"sectors":97,"benchmarks":152},"success",[33,41,48,55,61,68],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":39,"sparkline":40,"date":5},"SPX","S&P 500",7666.45,14.91,0.19,true,"0.0,3.1 2.3,5.0 4.6,8.0 6.9,10.4 9.3,13.4 11.6,9.1 13.9,11.5 16.2,13.8 18.5,16.0 20.8,10.3 23.2,9.5 25.5,2.0 27.8,2.0 30.1,5.9 32.4,6.0 34.7,3.4 37.1,7.3 39.4,8.2 41.7,9.4 44.0,8.5",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":39,"sparkline":47,"date":5},"NDX","NASDAQ 100",30501.56,93.06,0.31,"0.0,11.8 2.3,11.3 4.6,11.6 6.9,12.2 9.3,14.7 11.6,12.6 13.9,14.5 16.2,16.0 18.5,15.9 20.8,12.0 23.2,10.5 25.5,4.0 27.8,2.0 30.1,4.0 32.4,4.0 34.7,3.0 37.1,5.6 39.4,5.1 41.7,4.5 44.0,3.8",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":39,"sparkline":54,"date":5},"DJI","DOW JONES",50927,21,0.04,"0.0,2.0 2.3,3.4 4.6,6.5 6.9,8.6 9.3,10.2 11.6,7.6 13.9,8.4 16.2,10.0 18.5,13.2 20.8,11.6 23.2,12.1 25.5,10.2 27.8,11.2 30.1,12.9 32.4,13.8 34.7,11.4 37.1,13.1 39.4,13.8 41.7,16.0 44.0,15.9",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":53,"is_up":39,"sparkline":60,"date":5},"COMP","NASDAQ Composite",26871.6,10.53,"0.0,9.3 2.3,10.2 4.6,11.1 6.9,13.0 9.3,14.9 11.6,12.1 13.9,13.7 16.2,16.0 18.5,16.0 20.8,11.1 23.2,10.0 25.5,3.4 27.8,2.0 30.1,5.4 32.4,5.4 34.7,3.9 37.1,6.7 39.4,6.9 41.7,6.2 44.0,6.1",{"symbol":62,"name":63,"price":64,"change":65,"pct_change":66,"is_up":39,"sparkline":67,"date":5},"RUT","RUSSELL 2000",2790.2,11.3,0.41,"0.0,2.6 2.3,2.0 4.6,3.0 6.9,6.1 9.3,8.4 11.6,7.5 13.9,8.8 16.2,10.4 18.5,11.3 20.8,10.2 23.2,11.2 25.5,10.1 27.8,8.8 30.1,12.9 32.4,13.1 34.7,12.8 37.1,14.4 39.4,15.1 41.7,16.0 44.0,15.1",{"symbol":69,"name":70,"price":71,"change":72,"pct_change":46,"is_up":39,"sparkline":73,"date":5},"VIX","CBOE VIX",16.39,0.05,"0.0,15.6 2.3,14.8 4.6,10.2 6.9,7.3 9.3,2.0 11.6,9.7 13.9,4.9 16.2,4.5 18.5,2.5 20.8,11.3 23.2,13.7 25.5,13.5 27.8,16.0 30.1,12.3 32.4,10.4 34.7,13.5 37.1,8.8 39.4,8.9 41.7,7.8 44.0,7.6",[75,82,90],{"symbol":76,"name":77,"price":78,"change":79,"pct_change":80,"is_up":39,"sparkline":81,"date":5},"NVDA","NVIDIA Corp",230.86,2.48,1.09,"0.0,13.9 7.3,16.0 14.7,14.9 22.0,6.5 29.3,10.1 36.7,7.5 44.0,2.0",{"symbol":83,"name":84,"price":85,"change":86,"pct_change":87,"is_up":88,"sparkline":89,"date":5},"AAPL","Apple Inc",330.32,-2.7,-0.81,false,"0.0,6.9 7.3,8.2 14.7,2.0 22.0,5.2 29.3,16.0 36.7,11.7 44.0,14.9",{"symbol":91,"name":92,"price":93,"change":94,"pct_change":95,"is_up":88,"sparkline":96,"date":5},"TSLA","Tesla Inc",354.11,-0.7,-0.2,"0.0,2.0 7.3,3.1 14.7,6.1 22.0,13.6 29.3,16.0 36.7,15.0 44.0,15.3",[98,103,108,113,118,123,128,133,137,142,147],{"name":99,"etf":100,"change":101,"price":102,"is_up":39},"Technology","XLK",1.05,197.81,{"name":104,"etf":105,"change":106,"price":107,"is_up":39},"Financials","XLF",0.11,53.46,{"name":109,"etf":110,"change":111,"price":112,"is_up":88},"Healthcare","XLV",-1.32,166.2,{"name":114,"etf":115,"change":116,"price":117,"is_up":88},"Consumer Cycl","XLY",-0.03,108.81,{"name":119,"etf":120,"change":121,"price":122,"is_up":88},"Consumer Staples","XLP",-0.33,80.33,{"name":124,"etf":125,"change":126,"price":127,"is_up":39},"Energy","XLE",1.95,62.7,{"name":129,"etf":130,"change":131,"price":132,"is_up":39},"Industrials","XLI",0.99,168.64,{"name":134,"etf":135,"change":121,"price":136,"is_up":88},"Materials","XLB",48.54,{"name":138,"etf":139,"change":140,"price":141,"is_up":88},"Real Estate","XLRE",-0.56,40.68,{"name":143,"etf":144,"change":145,"price":146,"is_up":39},"Utilities","XLU",0.61,39.68,{"name":148,"etf":149,"change":150,"price":151,"is_up":88},"Comm Services","XLC",-0.93,109.94,[153,158,162,167],{"ticker":154,"name":155,"price":156,"change":157,"is_up":39},"SPY","SPDR S&P 500 ETF",763.99,0.18,{"ticker":159,"name":160,"price":161,"change":46,"is_up":39},"QQQ","Invesco QQQ Trust",742.03,{"ticker":163,"name":164,"price":165,"change":166,"is_up":39},"DIA","SPDR Dow Jones ETF",508.68,0.03,{"ticker":168,"name":169,"price":170,"change":171,"is_up":39},"IWM","iShares Russell 2000",279.06,0.42,{"ticker":4,"count":173,"articles":174},20,[175,181,187,193,199,205,211,217,222,227,232,237,242,247,252,257,262,267,272,277],{"title":176,"link":177,"pubDate":178,"description":179,"source":180},"Adaptive Biotechnologies (ADPT) Stock Could Be 26% Above Fair Value Despite Guideline Update - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqgFBVV95cUxNdXFSdml2cjlWRjROY3pGbW5UR1lpRGlHSzhaRFRkd1dGTXFLSG9wZXZpR0tUSlN3RVVldE50NFp6OGE5LVBIQ2JNcW54S21OeW1PU2FNb1FXQUtDTTFPU2UwNWJ0MWZpdmxGekliRzU4ZTZhWWZNMUhicjVZTFc1U3I1M0VUdWFUVzFXV3RwUVVUcV9fSEZzbjF4UWdjZjRJX3JEaWFiUU04Zw?oc=5","Fri, 25 Sep 2026 21:06:32 GMT","Adaptive Biotechnologies (ADPT) Stock Could Be 26% Above Fair Value Despite Guideline Update Yahoo Finance","Yahoo Finance",{"title":182,"link":183,"pubDate":184,"description":185,"source":186},"Adaptive Biotechnologies (NASDAQ:ADPT) Stock Rated \"Buy\" in New Coverage at The Goldman Sachs Group - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi7gFBVV95cUxQeVR6M2dYNzlxLU04S2drM1FKMjVycjdlQzVVMGZSLXNQRmVmM0JxVWlON0pZSng3T3JuM3F4TG1ZeWRvcnhOUWd6VUtVVTk2UkZWeGdqMmQ0OGl2Qk9PdnZ5N3Y2MUN3ZG4xVmhDeWZWVGNuR2NwNFN5RldaWlFsTGR3NmJqYVdVOHhoNlBSOGlhdzVYZHRfUTN3M3c0emhVVmFRbFhuSW53dmxLNGVtTWFvUGhQQmN3WUZNZmxQam1yeGRBaS1XTW9LZE1EbjlyZktPV3dxQUgzTTNDUk9MQm5rZ2dxQ1gtcDJJQ1dB?oc=5","Tue, 29 Sep 2026 12:14:57 GMT","Adaptive Biotechnologies (NASDAQ:ADPT) Stock Rated \"Buy\" in New Coverage at The Goldman Sachs Group MarketBeat","MarketBeat",{"title":188,"link":189,"pubDate":190,"description":191,"source":192},"A new myeloma cure definition requires tests able to detect one myeloma cell among a million. - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuwFBVV95cUxQWmsxazQtbTZGOW56bzduaTl6bWxQelctTndhUG1aVmNIS0k3c0Nmb01PZVZjRW8xM1VVcFB4NXlYZkc5bGxBY3QtbEZFYkVFaWM1NEs3M2I4bHI5M3lxekZkcUthS2hXMGtvTVlzNHFFa2N4SDhFOEtuNGZOZVNCUkR6MGExVjFKMlFGcUYxZFNMZXFJUXkxOGp6TDdrbGx5MnZvcHdMR0ZkWWs5ODhBdXlRRlJDdEVSSGlJ?oc=5","Fri, 25 Sep 2026 12:03:00 GMT","A new myeloma cure definition requires tests able to detect one myeloma cell among a million. Stock Titan","Stock Titan",{"title":194,"link":195,"pubDate":196,"description":197,"source":198},"Adaptive Biotechnologies Corp (ADPT) Stock Up 6.0% but GF Value Says Overvalued -- GF Score: 68\u002F100 - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiyAFBVV95cUxOX0V6LUZGYlBJTXRWSDFieXYycV9OdFF6TFRIbkZhTEZmZnRSWGZXZERrckY2Unp0RVRhRTI1b1doZDAtNjI0TDIwUnRKY28weDZKVTYyME1CSTN3OXBxSENFQndFbmdNQl9BSnoxMFNYVXNfSi1qaTc3RDhhVE9CSkNDcm9JNmt2SWd4amxUOGlCbEVDdWZDWF9uOS04eWtNdTQxb3NRUUlsSU5tVkMzMEJUSGpoS01SYU9STkd4S0d1RF9lQ2Jlcg?oc=5","Thu, 24 Sep 2026 23:01:57 GMT","Adaptive Biotechnologies Corp (ADPT) Stock Up 6.0% but GF Value Says Overvalued -- GF Score: 68\u002F100 GuruFocus","GuruFocus",{"title":200,"link":201,"pubDate":202,"description":203,"source":204},"Adaptive Biotechnologies slips as recent rally cools despite no clear new negative catalyst - Quiver Quantitative","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwgFBVV95cUxPSW5Fd3F4NlUyQ0RROFFCa0RiYm1wdnQ5RUlmUm5uNWYxSVkyUnFfRS1abnRXa3E0amR5WEoyRmVSRHBQdXE5Uy1sNjV5b1BqYU5GS0UwTUhfM0hjWnM1RFNlZEhmZDdBWUplRlVTQWVWdVdTRG5DTHM1T3NnYl8yVmtQV3gtT01lVnJydVVvamQ1WWQxc3JWdjJpN0lzR1pFMHlrTzBLRHcxNnBzRkFycHdwZGtlUG1iRTJkcmhEaGY3UQ?oc=5","Thu, 01 Oct 2026 17:37:00 GMT","Adaptive Biotechnologies slips as recent rally cools despite no clear new negative catalyst Quiver Quantitative","Quiver Quantitative",{"title":206,"link":207,"pubDate":208,"description":209,"source":210},"How NCCN Guideline Changes At Adaptive Biotechnologies (ADPT) Have Changed Its Investment Story - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Wed, 23 Sep 2026 21:34:29 GMT","How NCCN Guideline Changes At Adaptive Biotechnologies (ADPT) Have Changed Its Investment Story Simply Wall Street","Simply Wall Street",{"title":212,"link":213,"pubDate":214,"description":215,"source":216},"Adaptive Biotechnologies CPO Francis Lo sells $3.2 million in stock By Investing.com - Investing.com Nigeria","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixAFBVV95cUxPdDdKemVJSDg0T190SW52T3VLeVcwdmZGX2V4WS1fcm5ZZFhXczU3WHNyemVwRlhyTXNhaC1HOUJDQmdUZ1VSNUVRNkJSejg5M0JTTVVKWUZNN0hDRTZfNGdVdGtHTjFPazFJUllYUmJDLUtzX1RJakhXaTBlWV9ycnlUQk9TSDFua0NlSGtHUGxiZThBNWhrREw1eUxWWENXa0lGTHZfM3ZjVlZqV25mdkdUSWpfNkJLTkZOMVlRajJBbjZr?oc=5","Mon, 28 Sep 2026 08:42:16 GMT","Adaptive Biotechnologies CPO Francis Lo sells $3.2 million in stock By Investing.com Investing.com Nigeria","Investing.com Nigeria",{"title":218,"link":219,"pubDate":220,"description":221,"source":180},"Adaptive Biotechnologies (ADPT) Jumped, So What Is Driving Attention Now? - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqAFBVV95cUxPV01ELWxkYVFXWXF2VDlHN1RoYS1MQlFqcGprXzZwdE94TXpLNl9KTjdPR1ZheTlRNjFvbWN2WnQ1cXdlbU43MnZTOXAzNlZDY2FYQVlaT0hfR0N1WDhYbFpHQkxwVzdSZ3R6bm1hUGQ1dURuTFpMS0RyNTBvZkxjTlRLclJuQnZrcDh0UFdfdkRzTEdlT0NOanM2OGZGejZkNXlvbE9HM0g?oc=5","Fri, 25 Sep 2026 04:24:00 GMT","Adaptive Biotechnologies (ADPT) Jumped, So What Is Driving Attention Now? Yahoo Finance",{"title":223,"link":224,"pubDate":225,"description":226,"source":198},"Adaptive Biotechnologies Corp (ADPT) Stock Down 3.1% but Still O - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwAFBVV95cUxQUUlrczdpUFdja1Z0dlZmRVhlV3FGYzBKd3BQV3pkRG1sdEU0clA4YVY0RU56VEk5VU8wQ08yMlBISk1WQjJhVVowVTR2MDVzanpVNUllQ2t0bG9vMEttMUZRcFdfR0wwdlo4MFVYek5lSDVIb1Z4UkZhMHZhaHFHWExqWHJlajJvWEhjWUFMd2dkY0dpMXFxeVZzYnpkaUpFVzZ2UzdDREl5VlhCTWZ4MlprdlVQZUN4TDdLQ3dyYjY?oc=5","Mon, 28 Sep 2026 23:33:48 GMT","Adaptive Biotechnologies Corp (ADPT) Stock Down 3.1% but Still O GuruFocus",{"title":228,"link":229,"pubDate":230,"description":231,"source":186},"Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Up 4.4% - Should You Buy? - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiyAFBVV95cUxPLWczWVVBS1V3ZE1zX0g0RE9LNUtvcERGcnpHa2tMSEhRY2FGOFlJQ180OXkxMHkxQkhYdUpNMHAxbEhSbG5KTnd0MXk3OE5YYVZTYnlWaWdMS2FsVGhTQmw3YmZBYnYzTlZvWjVXYkliNHE4bk1OTklkTE5qX1dXXzB0VFE5YkxqY21NWEhzTXc5V2g2WkNlUWhFX2xtaWNLWENRUk03SFBqQzJGU2xMaTUxRDJ6Qk9Ta0Q5SUQxVWtVdHZnUDcwNg?oc=5","Thu, 24 Sep 2026 17:44:39 GMT","Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Up 4.4% - Should You Buy? MarketBeat",{"title":233,"link":234,"pubDate":235,"description":236,"source":192},"Options exercised over three months will supply an officer's planned sale at Adaptive Biotechnologies (ADPT). - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqgFBVV95cUxNa25BX1hiR1l5QU5mMkstS1k4VHRoRkt2Z3RrQnZEcGd3OXJQTWUtUmx0N1lWYkFjMnBLb0FhZ0JMakpWRk5hUThyQzFYZFN4SHlEcWVndVJMOEh0em1NbDNBeW9KZ3FCbU1mTnZfVzJFbV9kVDVjN1lYN0ZfTmNNTEZwWjVlUTVxOGJ3Zmh1TzhQbU1YdW1mMHFTS2h6RG5mRnZCWTFqbUtRdw?oc=5","Thu, 01 Oct 2026 20:33:26 GMT","Options exercised over three months will supply an officer's planned sale at Adaptive Biotechnologies (ADPT). Stock Titan",{"title":238,"link":239,"pubDate":240,"description":241,"source":210},"Will NCCN Names MRD Test Change Adaptive Biotechnologies Stock Narrative - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Thu, 01 Oct 2026 02:19:44 GMT","Will NCCN Names MRD Test Change Adaptive Biotechnologies Stock Narrative Simply Wall Street",{"title":243,"link":244,"pubDate":245,"description":246,"source":186},"Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $34.00 at BTIG Research - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi2wFBVV95cUxOM0t5ZnNkcFlKRzJraldPNWlqWFFFZ09kc3c3OUdSR2w2MUt4ckFESXp0OVI5bXF1cnNoc2paaDFhMkJsd0Z2cmpndnpIc3JxQ3FObzZGSUkzd21fS0FOa1BuTlZiektMbVdBSllNZWg3eW1IbGFMTXdwb1FHbXcySFNia0F1bmU4bnhPcHhoT2FwaDc0Vmh2dzRnNjRjbXRjT3B1R0NnSkN2UkFBVDhTdjBGUDFqbTRWLW1mWUFNNUNiR0k2alpnTlJTTDZlMGRUT0stZldPd1lqVW8?oc=5","Tue, 22 Sep 2026 12:09:53 GMT","Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $34.00 at BTIG Research MarketBeat",{"title":248,"link":249,"pubDate":250,"description":251,"source":210},"Adaptive Biotechnologies (ADPT) Could Be 11% Overvalued Following The Guideline Update - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Mon, 21 Sep 2026 21:56:15 GMT","Adaptive Biotechnologies (ADPT) Could Be 11% Overvalued Following The Guideline Update Simply Wall Street",{"title":253,"link":254,"pubDate":255,"description":256,"source":198},"ADPT Initiates Coverage On Goldman Sachs -- Rating Set to Buy - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMingFBVV95cUxOb1BpWXpxWVFacm5teXl2MktoalY3TEw4SHljX2ZHOW9TMmhuU3BHQllvWnhpMFVwVWlGcDJXNmVVNFYteGl6RU4tQTNXUV9RVmstYVVFR3FQR1ZlaHdnbkJnbXRKb0lNQndHLWVSMkhzMndzZ2p4cGZuREYwclJhYlhzLURNTWVmNjR2akJnQ1VHVzFlTjU1Nkx3STNnUQ?oc=5","Tue, 29 Sep 2026 11:55:18 GMT","ADPT Initiates Coverage On Goldman Sachs -- Rating Set to Buy GuruFocus",{"title":258,"link":259,"pubDate":260,"description":261,"source":210},"Is Adaptive Biotechnologies (ADPT) Fully Valued After The NCCN Guideline Update? - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Tue, 29 Sep 2026 23:45:53 GMT","Is Adaptive Biotechnologies (ADPT) Fully Valued After The NCCN Guideline Update? Simply Wall Street",{"title":263,"link":264,"pubDate":265,"description":266,"source":186},"Bank of America Corp DE Makes New Investment in Adaptive Biotechnologies Corporation $ADPT - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi5AFBVV95cUxPTWpEVC1GZHVIYkpidEo4YklQblRkNUMzQldlRFhfRS1RSXppQXF0VHVWTE1GYzlPZlJYZkZfUUx6VG14dVp6R25OMkpWa2s0Y09kQmZKTVhXSDliMm1qNE1wVGZPcnlwN2h0dG10ckh3TndpU1F0SnlXNDhYNGxYM1Z6ZTBmWFl6VVpMNmE2RFJNdEZ0YXVNSzhEYkY4MXpETEM0R1I2b1NoTU5CZVZqQXpJVzlNdjc5Z1JCZk1Zc05KOVdtSlk4N2tUUHRFajBUd1VqX1I3Y2NzSnN3dFN5YmJwbFg?oc=5","Tue, 22 Sep 2026 07:10:01 GMT","Bank of America Corp DE Makes New Investment in Adaptive Biotechnologies Corporation $ADPT MarketBeat",{"title":268,"link":269,"pubDate":270,"description":271,"source":198},"ADPT Maintained by Guggenheim -- Price Target Raised to $32 - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimgFBVV95cUxQcV8xSTFHMy1TNW1HQ2pUODVYdV9ycFI1UlVwRUVTejVsVzlCcVYycTNVR0pvTVJsdUZ4NVo0ZGdhYjQ3MHNMcHBZQ2prMGpfQ2hfZl96c1NPSzlCVkhIZkc0UnQwMWVNZUxydll0YXdZaThzUXdMTUFnWFR6aU5GSHR1RWxNclJhM0x5c0RnT0w2Z3RYSnNuQTV3?oc=5","Thu, 01 Oct 2026 15:31:43 GMT","ADPT Maintained by Guggenheim -- Price Target Raised to $32 GuruFocus",{"title":273,"link":274,"pubDate":275,"description":276,"source":186},"Adaptive Biotechnologies (NASDAQ:ADPT) Reaches New 1-Year High - Should You Buy? - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0AFBVV95cUxOYjhCQjBUblNaS3IyMDRHRGlCRjMzQ3NyX0gyNUVQa1ViaFVLMExLdEo4Y19FQkVrS3duZlVWbXZPWEc5eU16cVlYYUZXRm95MGowejBUT2VGOW1EeU5YcW00OExDWnJURi1pVFRTT05YYkZjS053a1RKNzF3RXFZTFhiZFVLZFhqc3hqMW13RzhqaGdsSmRiUnBNc0xMM0NETTlkTk5FVlR4UjlFT3NYZ0M5V2tjeXdSUXFoQTE4QVNBbFpKUTBQR3FpSFVqUGpv?oc=5","Tue, 22 Sep 2026 08:46:26 GMT","Adaptive Biotechnologies (NASDAQ:ADPT) Reaches New 1-Year High - Should You Buy? MarketBeat",{"title":278,"link":279,"pubDate":280,"description":281,"source":186},"Tidal Investments LLC Takes $855,000 Position in Adaptive Biotechnologies Corporation $ADPT - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi4wFBVV95cUxOV0w4djZVUGRhbWxRT21kTy1MZ25BZGhRSlg4cTliM3VZaWtDcGNjek8xRkJRZDMyT0NocHpBcUpxQkZkS19rVjhfb2UtdTAwTGVKQkxYbEZsV0lDb2tFdHVCUS1kWG04N3FzWFRTMk9BeU1EblVYZFRFbmpHdW8xbHdFZ3lua2pSeWpyVjUzVlNmOVdIVkJHZjJQOU8tSU53WTFPUENQdmZGM01QMmtkbDN1Y1BWTnVSMVV2MlBUcEMtOURPQkl4aXMwc0lYcWJzU3NZY2tVRFpSRWotV21tb2gwRQ?oc=5","Mon, 21 Sep 2026 07:00:00 GMT","Tidal Investments LLC Takes $855,000 Position in Adaptive Biotechnologies Corporation $ADPT MarketBeat"]